What should be included in a SOAP note for a 57-year-old female presenting for her first clinic visit, who is postmenopausal for one year and requests laboratory testing and a screening mammogram?

SOAP Note for 57-Year-Old Postmenopausal Woman - First Clinic Visit

For this 57-year-old postmenopausal woman, order a screening mammogram now (she qualifies for biennial screening at age 55+), and obtain baseline laboratory testing including lipid panel, fasting glucose or HbA1c, and consider bone density screening if she has risk factors for osteoporosis (formal screening recommended at age 65 for average-risk women).

Subjective

Chief Complaint:

• First clinic visit, requesting laboratory testing and mammogram
• Reports no menstrual period for one year (postmenopausal)

History of Present Illness:

• Document last menstrual period date (approximately 12 months ago)
• Assess for vasomotor symptoms (hot flashes, night sweats) and their severity/impact on quality of life
• Screen for genitourinary syndrome of menopause (vaginal dryness, dyspareunia, urinary symptoms)
• Document any other menopausal symptoms affecting quality of life

Cardiovascular Risk Assessment:

• Smoking history (current, former, pack-years)
• Family history of premature cardiovascular disease
• Personal history of hypertension, diabetes, dyslipidemia
• Calculate or prepare to calculate 10-year atherosclerotic cardiovascular disease risk 1, 2

Cancer Screening History:

• Last mammogram date and results
• Last cervical cancer screening (Pap/HPV testing) and results
• Last colorectal cancer screening and method
• Family history of breast, ovarian, and colorectal cancers

Bone Health:

• History of fractures
• Risk factors for osteoporosis (smoking, alcohol use, corticosteroid use, family history)
• Current calcium and vitamin D intake

Psychosocial Screening:

• Depression screening
• Alcohol and substance use
• Sexual activity and risk factors for sexually transmitted infections
• Intimate partner violence screening 2, 3

Objective

Vital Signs:

• Blood pressure, heart rate, weight, height, BMI

Physical Examination:

• Cardiovascular: heart sounds, peripheral pulses
• Breast examination (though clinical breast examination is not recommended for screening per ACS guidelines 4)
• Pelvic examination if cervical cancer screening is due

Assessment

Primary Diagnoses:

1. Postmenopausal state - diagnosed clinically based on absence of menses for 12 months at age 57 1
2. Due for preventive health maintenance - mammography, laboratory screening, cardiovascular risk assessment

Risk Stratification:

• Cardiovascular disease risk: [to be calculated based on history and labs]
• Breast cancer risk: Average risk (no personal history, no known genetic mutations, no chest radiation) 4
• Osteoporosis risk: [assess based on risk factors; formal screening at age 65 if average risk] 2

Plan

Breast Cancer Screening

Order screening mammogram immediately - At age 57, she qualifies for biennial screening (every 2 years) per ACS guidelines, though annual screening remains an option based on shared decision-making 4. She is past the age 55 transition point where biennial screening is recommended.

Laboratory Testing

Order the following baseline labs:

• Lipid panel (total cholesterol, LDL, HDL, triglycerides) - essential for cardiovascular risk assessment 2, 3
• Fasting glucose or HbA1c - screen for diabetes as cardiovascular risk factor 2
• TSH if symptomatic or clinically indicated
• Consider baseline vitamin D level if risk factors for deficiency

Bone Density Screening

• Defer DEXA scan until age 65 if she is average risk (no fracture history, no high-risk medications, no significant risk factors) 2
• Order DEXA now if she has risk factors: prior fragility fracture, chronic corticosteroid use, smoking, excessive alcohol use, low body weight, or family history of osteoporosis

Cervical Cancer Screening

• Continue cervical cancer screening every 3-5 years (depending on method: co-testing vs. HPV alone) until age 65, then discontinue if adequate prior negative screening 2, 3

Colorectal Cancer Screening

• Ensure she is up to date with colorectal cancer screening (colonoscopy every 10 years, or alternative methods per guidelines for ages 45-75) 2, 3

Cardiovascular Risk Management

• Calculate 10-year ASCVD risk once labs return using pooled cohort equations 2, 3
• Counsel on lifestyle modifications: smoking cessation if applicable, alcohol moderation, healthy diet, regular exercise 1
• Consider statin therapy based on calculated risk and lipid levels

Menopausal Symptom Management

• If she has bothersome vasomotor symptoms: Discuss treatment options including menopausal hormone therapy (MHT) vs. non-hormonal therapies based on her cardiovascular risk profile and preferences 1
• For women <60 years or <10 years past menopause with bothersome symptoms and no contraindications, MHT is an option (estrogen alone if no uterus, estrogen plus progestogen if uterus intact) 1
• Use FDA-approved preparations, not custom-compounded hormones 1
• Shared decision-making approach for formulation, dose, and route 1

Additional Screening

• Depression screening
• Alcohol use disorder screening
• STI screening if high-risk sexual behavior
• Intimate partner violence screening 2, 3

Patient Education

• Discuss benefits and limitations of mammography screening 4
• Counsel on calcium (1200 mg daily) and vitamin D (800-1000 IU daily) intake for bone health
• Provide anticipatory guidance about menopausal symptoms and available treatments
• Discuss cardiovascular disease prevention strategies

Follow-up

• Return visit in 1-2 weeks to review laboratory results and mammogram
• Discuss cardiovascular risk calculation and any needed interventions
• Address any menopausal symptoms requiring treatment

Common Pitfalls to Avoid:

• Don't order FSH/estradiol levels - menopause is a clinical diagnosis based on 12 months of amenorrhea at this age 1
• Don't perform clinical breast examination for screening purposes 4
• Don't order DEXA routinely before age 65 in average-risk women 2
• Don't forget to calculate cardiovascular risk - this is the leading cause of death in postmenopausal women 2, 3